Literature DB >> 7315291

An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants.

R S Procianoy, J A Garcia-Prats, H M Hittner, J M Adams, A J Rudolph.   

Abstract

An association between cicatricial retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants was investigated retrospectively. Newborns were studied who weighed less than or equal to 1500 g at birth, who were less than or equal to 32 weeks gestational age and appropriate by weight, and admitted in the first 24 hours of life to our Neonatal Intensive Care Unit. Diagnosis of retinopathy of prematurity was made by retinal examination at approximately 4 weeks of age. Diagnosis of intraventricular hemorrhage was made by computerized tomography and clinical findings. A total of 138 infants were studied and divided into two groups: (A) birth weight less than or equal to 1000 g (31); (B) birth weight 1001--1500 g (107). There was a statistically significant association between cicatricial retinopathy of prematurity and intraventricular hemorrhage in both groups. There were no statistical differences between birth weight, gestational age, duration of oxygen therapy, highest oxygen concentration received, Apgar scores, incidence of hyaline membrane disease and patent ductus arteriosus between cicatricial retinopathy of prematurity and no retinopathy of prematurity patients in either group. This association may be an important consideration in the pathogenesis of both vascular diseases.

Entities:  

Mesh:

Year:  1981        PMID: 7315291     DOI: 10.1111/j.1651-2227.1981.tb05725.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  15 in total

1.  Intraventricular haemorrhage and stage 3 retinopathy of prematurity.

Authors:  P Watts; G G Adams; R M Thomas; C Bunce
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Serum fructosamine and retinopathy of prematurity.

Authors:  Senol Bozdag; Serife Suna Oguz; Tulin Gokmen; Zuhal Tunay; Levent Tok; Nurdan Uras; Omer Erdeve; Ugur Dilmen
Journal:  Indian J Pediatr       Date:  2011-07-06       Impact factor: 1.967

3.  Clinical factors associated with retinopathy of prematurity.

Authors:  A Prendiville; W E Schulenburg
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

4.  Blood gases and retinopathy of prematurity: the ELGAN Study.

Authors:  Alisse K Hauspurg; Elizabeth N Allred; Deborah K Vanderveen; Minghua Chen; Francis J Bednarek; Cynthia Cole; Richard A Ehrenkranz; Alan Leviton; Olaf Dammann
Journal:  Neonatology       Date:  2010-07-30       Impact factor: 4.035

5.  Retrolental fibroplasia may not be preventable.

Authors:  J F Lucey
Journal:  J R Soc Med       Date:  1982-07       Impact factor: 5.344

6.  A prospective study on hyperglycemia and retinopathy of prematurity.

Authors:  L Mohsen; M Abou-Alam; M El-Dib; M Labib; M Elsada; H Aly
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

7.  Ocular significance of intraventricular haemorrhage in premature infants.

Authors:  M O'Keefe; N Kafil-Hussain; I Flitcroft; B Lanigan
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

8.  Ocular sequelae of preterm birth and their relation to ultrasound evidence of cerebral damage.

Authors:  J Hungerford; A Stewart; P Hope
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

9.  Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies.

Authors:  Joao Borges Fortes Filho; Pedro P Bonomo; Mauricio Maia; Renato S Procianoy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

10.  The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP).

Authors:  Joao Borges Fortes Filho; Gabriela Unchalo Eckert; Fabiana Borba Valiatti; Paula Gabriela Batista Dos Santos; Marlene Coelho da Costa; Renato Soibelmann Procianoy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.